| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP0865495A4 Progestin-regulated gene |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | EP0547201B1 Phagemide for screening antibodies |
| 03/21/2001 | CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204370 MN gene and protein |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204363 Polypeptide associated with cell propagation; for the treatment of cell propagation defects in cells |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204038 Desaturase antigen of Mycobacterium tuberculosis |
| 03/20/2001 | US6204033 Preparation of polyvinyl alcohol-based magnetic particles for binding biomolecules |
| 03/20/2001 | US6204023 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 03/20/2001 | US6204019 Sec A2 from Streptococcus pneumoniae |
| 03/20/2001 | US6204018 66 kDa antigen from Borrelia |
| 03/20/2001 | US6204016 Tyrosylprotein sulfotransferases and methods of use thereof |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204010 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/20/2001 | US6204007 Antibodies against E-selectin |
| 03/20/2001 | US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 03/20/2001 | US6203979 Polynucleotide which codes for protein of defined amino acid sequences; diagnosis, prevention, and therapy of cell proliferative and immune disorders; anticarcinogenic agents; antiproliferative/antiarthritic agents; crohn's disease |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/20/2001 | US6203793 Compositions and methods for treating thermal injury |
| 03/20/2001 | CA2318519A1 Genes and polypeptides associated with ultraviolet radiation-mediated skin damage and uses thereof |
| 03/20/2001 | CA2211385C N-1-carboxyalkyl derivatives of lsd |
| 03/20/2001 | CA2022959C Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
| 03/15/2001 | WO2001018550A2 Determination of adrenomedullin-binding proteins |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018216A2 26176, a novel calpain protease and uses thereof |
| 03/15/2001 | WO2001018212A2 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | WO2001018196A1 Method of detecting trichothecene mycotoxins and reagent thereof |
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018059A2 Congener independent detection of microcystin and nodularin congeners |
| 03/15/2001 | WO2001018058A2 Enhanced phage display library of human vh fragments and methods for producing same |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017560A1 Method for treating and preventing bacterial infection |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017557A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000071152A9 Fibroblast growth factor 10 |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000044407A8 Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943839A1 Contactinhibin enthaltendes Arzneimittel sowie Arzneimittel, das gegen Contactinhibin gerichtete Antikörper enthält Contactinhibin medicated and drug containing antibodies directed against contactinhibin |
| 03/15/2001 | DE10044468A1 New nucleic acid encoding delta-6-desaturase, useful for producing ciliates and plants that overproduce unsaturated fatty acids, derived from Tetrahymena |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384405A1 Dendritic cell membrane protein fire |
| 03/15/2001 | CA2384388A1 Enhanced phage display library of human vh fragments and methods for producing same |
| 03/15/2001 | CA2384115A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383776A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383419A1 Determination of am-binding proteins and the association of adrenomedullin (am) therewith |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2377905A1 Method and reagent for detection of trichothecene mycotoxins |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/14/2001 | EP1083428A2 Method and reagent for the detection or determination of HCV core antigens |
| 03/14/2001 | EP1083226A1 Cell separation device and separation method |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |